Human botulism immune globulin for the treatment of infant botulism.

[1]  Possession, use, and transfer of select agents and toxins. Final rule. , 2008, Federal register.

[2]  S. Arnon,et al.  First Case of Infant Botulism Caused by Clostridium baratii Type F in California , 2005, Journal of Clinical Microbiology.

[3]  E. Vuori,et al.  Infant Botulism Acquired from Household Dust Presenting as Sudden Infant Death Syndrome , 2005, Journal of Clinical Microbiology.

[4]  S. Arnon,et al.  Dual Toxin-Producing Strain of Clostridium botulinum Type Bf Isolated from a California Patient with Infant Botulism , 2004, Journal of Clinical Microbiology.

[5]  L. Simpson,et al.  Identification of the major steps in botulinum toxin action. , 2004, Annual review of pharmacology and toxicology.

[6]  G. Chang,et al.  Early Antitoxin Treatment in Wound Botulism Results in Better Outcome , 2003, European Neurology.

[7]  F. Anniballi,et al.  A Case of Infant Botulism due to Neurotoxigenic Clostridium butyricum Type E Associated with Clostridium difficile Colitis , 2002, European Journal of Clinical Microbiology and Infectious Diseases.

[8]  Leonard A. Smith,et al.  Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Jerome Hauer,et al.  Botulinum toxin as a biological weapon , 2001 .

[10]  Philip K. Russell,et al.  Botulinum toxin as a biological weapon: medical and public health management. , 2001, JAMA.

[11]  G. Schiavo,et al.  Neurotoxins affecting neuroexocytosis. , 2000, Physiological reviews.

[12]  J. Bradley,et al.  Clostridium difficile colitis associated with infant botulism: near-fatal case analogous to Hirschsprung's enterocolitis. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  M. Schreiner,et al.  Infant botulism: a review of 12 years' experience at the Children's Hospital of Philadelphia. , 1991, Pediatrics.

[14]  P. Blake,et al.  Risk factors for infant botulism in the United States. , 1989, American journal of diseases of children.

[15]  R. Feigin,et al.  Textbook of Pediatric Infectious Diseases , 1986 .

[16]  P. Gilligan,et al.  Clinical, laboratory, and environmental features of infant botulism in Southeastern Pennsylvania. , 1985, Pediatrics.

[17]  J. Snyder,et al.  Antitoxin levels in botulism patients treated with trivalent equine botulism antitoxin to toxin types A, B, and E. , 1984, The Journal of infectious diseases.

[18]  C. Tacket,et al.  Equine antitoxin use and other factors that predict outcome in type A foodborne botulism. , 1984, The American journal of medicine.

[19]  S. Arnon,et al.  Protective role of human milk against sudden death from infant botulism. , 1982, The Journal of pediatrics.

[20]  D. Gill,et al.  Bacterial toxins: a table of lethal amounts , 1982, Microbiological reviews.

[21]  R. A. Groeneveld,et al.  Practical Nonparametric Statistics (2nd ed). , 1981 .

[22]  R. Black,et al.  Hypersensitivity reactions associated with botulinal antitoxin. , 1980, The American journal of medicine.

[23]  S. Arnon,et al.  Quantitative evidence of intestinal colonization by Clostridium botulinum in four cases of infant botulism. , 1980, The Journal of infectious diseases.

[24]  S. Arnon,et al.  Diagnosis and management of infant botulism. , 1979, American journal of diseases of children.

[25]  S. Arnon,et al.  Honey and other environmental risk factors for infant botulism. , 1979, The Journal of pediatrics.

[26]  S. Arnon,et al.  INFANT BOTULISM: PATHOGENESIS, CLINICAL ASPECTS AND RELATION TO CRIB DEATH1 , 1981 .

[27]  W. J. Conover,et al.  Practical Nonparametric Statistics , 1972 .